{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:33:15Z","timestamp":1760056395725,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["FNS-407240_177381","FNS-407240_177382"],"award-info":[{"award-number":["FNS-407240_177381","FNS-407240_177382"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005869","name":"University of Fribourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.diagmicrobio.2021.115475","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T03:32:14Z","timestamp":1625110334000},"page":"115475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of SuperCAZ\/AVI\u00ae Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates"],"prefix":"10.1016","volume":"101","author":[{"given":"Mustafa","family":"Sadek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Poirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Dominguez Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"D'Emidio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Pomponio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Nordmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0001","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3201\/eid2509.190656","article-title":"Epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital","volume":"25:","author":"Aires-de-Sousa","year":"2019","journal-title":"Portugal. Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0002","doi-asserted-by":"crossref","first-page":"e00528","DOI":"10.1128\/mBio.00528-17","article-title":"Klebsiella pneumoniae carbapenemase-2 (KPC-2), substitutions at ambler position Asp179, and resistance to ceftazidime-avibactam: unique antibiotic-resistant phenotypes emerge from \u03b2-lactamase protein engineering","volume":"8:","author":"Barnes","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0003","doi-asserted-by":"crossref","first-page":"e01429","DOI":"10.1128\/AAC.01429-20","article-title":"KPC-53, a KPC-3 variant of clinical origin associated with reduced susceptibility to ceftazidime-avibactam","volume":"65:","author":"Di Pilato","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"year":"2021","series-title":"The European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for Interpretation of MICs and Zone Diameters, Version v11.0","key":"10.1016\/j.diagmicrobio.2021.115475_bib0004"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0006","first-page":"e02101","article-title":"Successive emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in blaKPC-2-harboring Klebsiella pneumoniae sequence type 307 isolates","volume":"62:","author":"Giddins","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0007","doi-asserted-by":"crossref","first-page":"e02534","DOI":"10.1128\/AAC.02534-16","article-title":"Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum \u03b2-lactamases","volume":"61:","author":"Haidar","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0008","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jac\/dkz026","article-title":"Ceftazidime\/avibactam resistance associated with L169P mutation in the omega loop of KPC-2","volume":"74:","author":"Hemarajata","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0009","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1128\/AAC.00107-16","article-title":"Global dissemination of blaKPC into bacterial species beyond Klebsiella pneumoniae and in vitro susceptibility to ceftazidime-avibactam and aztreonam-avibactam","volume":"60:","author":"Kazmierczak","year":"2016","journal-title":"Antimicr Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0010","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1128\/AAC.00678-15","article-title":"In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase","volume":"59:","author":"Livermore","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0011","doi-asserted-by":"crossref","first-page":"e01111","DOI":"10.1128\/AAC.01111-19","article-title":"Phenotypic, biochemical and genetic analysis of KPC-41, a KPC-3 variant conferring resistance to ceftazidime-avibactam and exhibiting reduced carbapenemase activity","volume":"63:","author":"Mueller","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0012","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13:","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0013","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1128\/JCM.06477-11","article-title":"Detection of carbapenemase producers in Enterobacteriaceae by use of a novel screening medium","volume":"50:","author":"Nordmann","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0014","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/jac\/dkz149","article-title":"ESBLs and resistance to ceftazidime\/avibactam and ceftolozane\/tazobactam combinations in Escherichia coli and Pseudomonas aeruginosa","volume":"74:","author":"Ortiz de la Rosa","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0015","doi-asserted-by":"crossref","first-page":"e00321","DOI":"10.1128\/AAC.00321-20","article-title":"KPC-50 confers resistance to ceftazidime\/avibactam associated with reduced carbapenemase activity","volume":"64:","author":"Poirel","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0016","first-page":"e00965","article-title":"A selective culture medium for screening ceftazidime-avibactam resistance in Enterobacterales and Pseudomonas aeruginosa","volume":"58:","author":"Sadek","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0017","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clinthera.2016.01.018","article-title":"A novel cephalosporin\/\u03b2-lactamase inhibitor combination for the treatment of resistant gram-negative organisms","volume":"38:","author":"Sharma","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0018","first-page":"e02097","article-title":"Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections","volume":"61:","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0019","doi-asserted-by":"crossref","first-page":"e02497","DOI":"10.1128\/AAC.02497-17","article-title":"Pneumonia and renal replacement therapy are risk factors for ceftazidime-avibactam treatment failures and resistance among patients with carbapenem-resistant Enterobacteriaceae infections","volume":"62:","author":"Shields","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations","volume":"63:","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0021","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/IDR.S207993","article-title":"Molecular and phenotypical characterization of two cases of antibiotic-driven ceftazidime-avibactam resistance in blaKPC-3-harboring Klebsiella pneumoniae","volume":"12:","author":"Venditti","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0022","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/jac\/dkv094","article-title":"Activity of ceftazidime\/avibactam against isogenic strains of Escherichia coli containing KPC and SHV \u03b2-lactamases with single amino acid substitutions in the omega-loop","volume":"70:","author":"Winkler","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0023","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cmi.2017.09.001","article-title":"New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?","volume":"23:","author":"Wright","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0024","article-title":"Epidemiology and mechanisms of ceftazidime\u2013avibactam resistance in gram-negative bacteria","author":"Xu","year":"2021","journal-title":"Engineering"},{"key":"10.1016\/j.diagmicrobio.2021.115475_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40265-013-0013-7","article-title":"Ceftazidime-avibactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination","volume":"73:","author":"Zhanel","year":"2013","journal-title":"Drugs"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321001681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321001681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:56:11Z","timestamp":1760003771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889321001681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0732889321001681"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115475","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of SuperCAZ\/AVI\u00ae Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115475"}}